Verana Health
186 employees
Data & Analytics
Series E · $288.8M
Open positions (5)
Company details
Team Size186
IndustryData & Analytics
Funding
Total raised
$288.8M
Last stage
Series E
Investors
Novo Holdings
Total raised
$288.8M
Last stage
Series E
Investors
David W. Parke II
Former CEO of the American Academy of Ophthalmology (AAO). Served 17 years as president and CEO of Dean McGee Eye Institute and Professor/Chair of Ophthalmology at University of Oklahoma. Co-founder who transitioned to Executive Chairman when Sujay Jadhav became CEO in 2021.
Mark Blumenkranz
Co-founder of Verana Health with background in medicine and ophthalmology.
Miki Kapoor
Twenty years of healthcare experience across operations, finance, strategy, and policy. Previously Head of Global Payer and Provider Division at IMS Health, EVP of Health Systems at the Clinton Foundation, and advisor at McKinsey & Company. Holds MBA and MPH from Yale University.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.